Cancer treatment for hematological malignancies traditionally included systemic chemotherapy and localized radiotherapy for central nervous system (CNS) disease. These therapies in addition to their adverse effects’ profile ...

C-reactive protein is a non-specific indicator of inflammation. The CRP test is useful in evaluating patients with an acute myocardial infarction (AMI). The level of CRP correlates with peak levels of the CK-MB isoenzyme, ...

The glycopeptide antibiotic vancomycin is frequently used as the drug of choice for the treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA). MRSA has been reported to cause severe life ...

The Kell blood group system is an interesting mix of high-frequency and low-frequency antigens. It consists of 25 antigens, which include six pairs or triplets of antithetical antigens. All of these polymorphisms represent ...

The monoclonal antibody 7E11-C5.3 was the first anti-PSMA antibody to be developed. It recognizes a PSMA intracellular epitope, is radio-labeled and used to detect early recurrent and metastatic prostate cancer. The ...

Diabetes mellitus (DM) is a common disorder in the Palestinian population. It causes economic burden on the society due to costs of management of the disease. Therefore, being able to predict the development of type 1 DM ...

The expression of immune checkpoint molecules such as programmed cell death ligand 1 (PD-L1) on the surface of cancer cells and programmed cell death 1 (PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA-4) on the ...

Adoptive cellular therapy (ACT) has shown promise for the treatment of cancer specifically the use of chimeric antigen receptor (CAR) T cell therapy for leukemias and lymphomas. But the translation of this success to solid ...